Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Precision System Science Co (TSE:7707) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Precision System Science Co EBITDA Margin % Related Terms
Precision System Science Co EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:7707 vs ABT, SYK, MDT: EBITDA Margin % Comparison
For the Medical Devices subindustry, Precision System Science Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Precision System Science Co EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Precision System Science Co's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Precision System Science Co's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Precision System Science Co (TSE:7707) has a EBITDA Margin % of 9.35% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Precision System Science Co and its competitors. According to the industry distribution chart, Precision System Science Co ranks #364 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 44.6%.
Is Precision System Science Co's EBITDA Margin % too high?
Precision System Science Co's current EBITDA Margin % is 9.35%. The Medical Devices & Instruments industry median EBITDA Margin % is 7.59. Precision System Science Co's value of 9.35% is 23.2% above this industry median. Based on the distribution chart, Precision System Science Co ranks #364 out of 816 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Precision System Science Co has a GF Score™ of 53/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Precision System Science Co's EBITDA Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Precision System Science Co ranks #364 out of 816 companies for EBITDA Margin %. This puts Precision System Science Co in the upper half of its industry. The industry median EBITDA Margin % is 7.59. Precision System Science Co's value of 9.35% is 23.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.59, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Precision System Science Co's current EBITDA Margin % of 9.35% is 23.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Precision System Science Co and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.59 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Precision System Science Co's current EBITDA Margin % is 9.35%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Precision System Science Co stock overvalued right now?
Based on GuruFocus' analysis, Precision System Science Co (TSE:7707) is currently considered Modestly Undervalued. The stock's GF Value™ is 円248.70, compared to a current price of 円211.00 — trading 15.2% below its estimated fair value. The current EBITDA Margin % is 9.35% and 23.2% above the Medical Devices & Instruments industry median of 7.59. Precision System Science Co's overall GF Score™ is 53/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Precision System Science Co (TSE:7707), the current EBITDA Margin % is 9.35% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Precision System Science Co (TSE:7707) Overvalued in 2026?
Based on GuruFocus' analysis, Precision System Science Co stock appears to be undervalued.
The current stock price of 円211.00 is trading 15.2% below its estimated GF Value™ of 円248.70.
GuruFocus considers Precision System Science Co to be Modestly Undervalued.
Key valuation signals for TSE:7707:
EBITDA Margin %: 9.35%
GF Value™: 円248.70 vs. price of 円211.00 (15.2% below fair value)
Industry Position: 23.2% above the Medical Devices & Instruments median (#364 of 816)
No single metric tells the full story. See the TSE:7707 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Precision System Science Co Ltd is engaged in the development, manufacture, and sale of vitro diagnosis like genetic testing, protein inspection, automation equipment. The company is also engaged in production and sales of reagents and plastic consumables.
53GF Score
Get the complete analysis for TSE:7707
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7707 has been successfully added to your 
